Search results will open in a new window on

TSX Delisting Review – Acerus Pharmaceuticals Corporation. (ASP, ASP.WT)

February 13, 2020
Issuer: Acerus Pharmaceuticals Corporation
Securities: Common shares Common share purchase warrants
Symbol(s): ASP ASP.WT
Delisting Review Type: Remedial
Delisting Review Period: 120 days to regain compliance with continued listing requirements.
TSX contact: Chris Birkett, Director, Toronto Stock Exchange.